Arrowstreet Capital
EXAS

Arrowstreet Capital’s Exact Sciences EXAS Stock Holding History

Arrowstreet Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-573,185
Closed -$58.2M – 1925
2025
Q4 		$58.2M Buy
573,185
+229,822
+67% +$18.5M 0.03% 433
2025
Q3 		$18.8M Buy
+343,363
New +$17.2M 0.01% 754
2024
Q2 		– Sell
-41,449
Closed -$2.86M – 1594
2024
Q1 		$2.86M Sell
41,449
-14,347
-26% -$908K ﹤0.01% 1047
2023
Q4 		$4.13M Buy
+55,796
New +$3.66M ﹤0.01% 805
2023
Q3 		– Sell
-13,426
Closed -$1.26M – 1305
2023
Q2 		$1.26M Buy
+13,426
New +$1.05M ﹤0.01% 932
2017
Q3 		– Sell
-27,275
Closed -$965K – 1142
2017
Q2 		$965K Buy
+27,275
New +$842K ﹤0.01% 787

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Arrowstreet Capital's EXAS Position: Q1 2026 in Review

Arrowstreet Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 573,185 shares — an estimated $58.2M sold.

Arrowstreet Capital first reported a position in EXAS in Q2 2017 and held it in 6 quarters. The position peaked at $58.2M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Arrowstreet Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Arrowstreet Capital sold 573,185 Exact Sciences shares in Q1 2026, an estimated $58.2M.
  • Arrowstreet Capital first reported a position in Exact Sciences in Q2 2017 and held it in 6 quarters.
  • Arrowstreet Capital's Exact Sciences position peaked at $58.2M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.